Exact Mass: 474.2550334
Exact Mass Matches: 474.2550334
Found 258 metabolites which its exact mass value is equals to given mass value 474.2550334
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lucidenic acid B
Lucidenic acid E1 is found in mushrooms. Lucidenic acid E1 is a constituent of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Lucidenic acid B is found in mushrooms.
Lucidenic acid I
Lucidenic acid I is found in mushrooms. Lucidenic acid I is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Lucidenic acid I is found in mushrooms.
Lucidenic acid L
Lucidenic acid L is found in mushrooms. Lucidenic acid L is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Lucidenic acid L is found in mushrooms.
mTOR-IN-1
C25H30N8O2 (474.24915999999996)
LucidenicacidB
Lucidenic acid B is a triterpenoid. Lucidenic acid B is a natural product found in Ganoderma lucidum with data available. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
20-hydroxylucidinic acid A|7beta,20xi-dihydroxy-3,11,15-trioxo-25,26,27-trinorlanost-8-en-24-oic acid
13-acetoxy-7beta,9-diangeloyloxy-3betaH-longipinan-1-one
(1R*,2S*,6E,10S*,11Z,14S*)-14-acetoxy-5-hydroxy-18-oxobriara-6,8(17),11-trien-2-yl 3-methylbutanoate
7beta,9alpha-diangeloyloxy-8alpha-acetyloxylongipinan-1-one
8-acetoxy-1beta,2beta-diangeloyloxy-3beta,4beta-epoxy-bisobola-7(14),10-diene
(+)-pseudopterosin P|(1S,3R,7S,9aR)-6-(acetyloxy)-2,3,7,8,9,9a-hexahydro-1,4,7-trimethyl-3-(2-methylprop-1-enyl)-1H-phenalen-5-yl beta-L-xylopyranoside
caseabalansin G|rel-(5R,6R,8S,9S,10R,18S,19R)-19-acetoxy-18-butanoyloxy-18,19-epoxy-6-methoxycleroda-3,13(16),14-trien-2-one
4,5,5,6,6-Pentamethoxy-10-isobutyloxy-8,9-dimethyl-2,2-butanobiphenyl-4-ol
2-acetamido-N-[1-[2-(1H-indol-3-yl)ethenylamino]-1-oxo-3-phenylpropan-2-yl]-N,4-dimethylpentanamide
C28H34N4O3 (474.26307740000004)
12-Deoxy-4betaOH-phorbol-13-alpha-methylbutyrat-20-acetat
2,3-Di-Ac -(2alpha,3beta,5alpha,14beta)-2,3,14-Trihydroxycard-20(22)-enolide
15-O-acetyl-3-O-tigloylcharaciol-5beta,6beta-oxide
Ajugacumbin B
Ganoderlactone D
1-Hydroxy-2-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphoethanolamine
[C23H41NO7P]- (474.26205060000007)
Ala Ala Lys Trp
Ala Ala Trp Lys
Ala Lys Ala Trp
Ala Lys Trp Ala
Ala Gln Arg Thr
Ala Gln Thr Arg
Ala Arg Gln Thr
Ala Arg Thr Gln
Ala Thr Gln Arg
Ala Thr Arg Gln
Ala Trp Ala Lys
Ala Trp Lys Ala
Cys Lys Lys Pro
Cys Lys Pro Lys
Cys Pro Lys Lys
Asp Gly Lys Arg
Asp Gly Arg Lys
Asp Lys Gly Arg
Asp Lys Arg Gly
Asp Arg Gly Lys
Asp Arg Lys Gly
Gly Asp Lys Arg
Gly Asp Arg Lys
Gly Lys Asp Arg
Gly Lys Arg Asp
Gly Arg Asp Lys
Gly Arg Lys Asp
Lys Ala Ala Trp
Lys Ala Trp Ala
Lys Cys Lys Pro
Lys Cys Pro Lys
Lys Asp Gly Arg
Lys Asp Arg Gly
Lys Gly Asp Arg
Lys Gly Arg Asp
Lys Lys Cys Pro
Lys Lys Pro Cys
Lys Pro Cys Lys
Lys Pro Lys Cys
Lys Arg Asp Gly
Lys Arg Gly Asp
Lys Trp Ala Ala
Asn Arg Ser Val
Asn Arg Val Ser
Asn Ser Arg Val
Asn Ser Val Arg
Asn Val Arg Ser
Asn Val Ser Arg
Pro Cys Lys Lys
Pro Lys Cys Lys
Pro Lys Lys Cys
Pro Pro Val Tyr
Pro Pro Tyr Val
Pro Val Pro Tyr
Pro Val Tyr Pro
Pro Tyr Pro Val
Pro Tyr Val Pro
Gln Ala Arg Thr
Gln Ala Thr Arg
Gln Arg Ala Thr
Gln Arg Thr Ala
Gln Thr Ala Arg
Gln Thr Arg Ala
Arg Ala Gln Thr
Arg Ala Thr Gln
Arg Asp Gly Lys
Arg Asp Lys Gly
Arg Gly Asp Lys
Arg Gly Lys Asp
Arg Lys Asp Gly
Arg Lys Gly Asp
Arg Asn Ser Val
Arg Asn Val Ser
Arg Gln Ala Thr
Arg Gln Thr Ala
Arg Ser Asn Val
Arg Ser Val Asn
Arg Thr Ala Gln
Arg Thr Gln Ala
Arg Val Asn Ser
Arg Val Ser Asn
Ser Asn Arg Val
Ser Asn Val Arg
Ser Arg Asn Val
Ser Arg Val Asn
Ser Val Asn Arg
Ser Val Arg Asn
Thr Ala Gln Arg
Thr Ala Arg Gln
Thr Gln Ala Arg
Thr Gln Arg Ala
Thr Arg Ala Gln
Thr Arg Gln Ala
Val Asn Arg Ser
Val Asn Ser Arg
Val Pro Pro Tyr
Val Pro Tyr Pro
Val Arg Asn Ser
Val Arg Ser Asn
Val Ser Asn Arg
Val Ser Arg Asn
Val Tyr Pro Pro
Trp Ala Ala Lys
Trp Ala Lys Ala
Trp Lys Ala Ala
Tyr Pro Pro Val
Tyr Pro Val Pro
Tyr Val Pro Pro
Lucidenic acid L
Lucidenic acid I
lucidenic acid B
hexanedioic acid,2-(2-hydroxyethoxy)ethanol,5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane
butyl prop-2-enoate,methyl 2-methylprop-2-enoate,oxiran-2-ylmethyl 2-methylprop-2-enoate,styrene
10-Undecenoic acid,tributylstannyl ester
C23H46O2Sn (474.25196059999996)
[14-acetyloxy-3-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] acetate
[(1R)-1-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-pyridin-4-ylmethanone
C28H34N4O3 (474.26307740000004)
(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C28H34N4O3 (474.26307740000004)
2-methoxy-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxazolylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
[(1S)-1-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-pyridin-4-ylmethanone
C28H34N4O3 (474.26307740000004)
4-[3,6-bis(dimethylamino)acridin-10-ium-10-yl]-N-[2-(2,5-dioxopyrrol-1-yl)ethyl]butanamide
[16-acetyloxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate
1-Hydroxy-2-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphoethanolamine
C23H41NO7P- (474.26205060000007)
12-Deoxy-phorbol-13-alpha-methylbutyrate-20-acetate
12-deoxyphorbol 20-acetate 13-(2-methylbutanoate)
A phorbol ester that is 12-deoxyphorbol in which the hydroxy groups at positions 13 and 20 have been converted to their respective 2-methylbutanoate and acetate esters.
mTOR inhibitor-3
C25H30N8O2 (474.24915999999996)
mTOR inhibitor-3 is a remarkably selective mTOR inhibitor with a Ki of 1.5 nM. mTOR inhibitor-3 suppresses mTORC1 and mTORC2 in cellular and in vivo pharmacokinetic (PK)/pharmacodynamic (PD) experiments. mTOR inhibitor-3 is a remarkably selective mTOR inhibitor with a Ki of 1.5 nM. mTOR inhibitor-3 suppresses mTORC1 and mTORC2 in cellular and in vivo pharmacokinetic (PK)/pharmacodynamic (PD) experiments.
(2s)-2-[(2s)-2-[(1-hydroxyethylidene)amino]-n,4-dimethylpentanamido]-n-[(1e)-2-(1h-indol-3-yl)ethenyl]-3-phenylpropanimidic acid
C28H34N4O3 (474.26307740000004)
(3s,3ar,6s,6ar,10s,15as)-1,6-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10-trimethyl-3h,3ah,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindole-12,15-dione
C29H34N2O4 (474.25184440000004)
4-{4,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid
(1s,2s,3ar,13s,13as)-3a-(acetyloxy)-13-hydroxy-2,5,8,8-tetramethyl-12-methylidene-4,9-dioxo-1h,2h,3h,7h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl (2e)-2-methylbut-2-enoate
(1r,2r,6r,10s,11r,13s,15r)-8-[(acetyloxy)methyl]-1,6-dihydroxy-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl 2,2-dimethylpropanoate
8-[(acetyloxy)methyl]-1,6-dihydroxy-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl 2-methylbutanoate
2-{2-[(1-hydroxyethylidene)amino]-n,4-dimethylpentanamido}-n-[2-(1h-indol-3-yl)ethenyl]-3-phenylpropanimidic acid
C28H34N4O3 (474.26307740000004)
10-hydroxy-5,7-dimethoxy-1,14,18,18-tetramethyl-2,6-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3(11),4(8),9-trien-17-yl acetate
[4,7-bis(acetyloxy)-1-ethenyl-10-hydroxy-11a-methyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9a-yl]methyl acetate
(4r,6s,6ar,9s)-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-2-{[(2r,3s,4r,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-5,6,6a,7,8,9-hexahydro-4h-phenalen-1-yl acetate
9-formyl-5,9,13-trimethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate
[(1s,4s,5s,6r,9s,10r,12r,14r)-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxo-4-(propanoyloxy)tetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-7-yl]methyl 2-methylpropanoate
4,5-dihydroxy-2-{[2-hydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalen-1-yl]oxy}oxan-3-yl acetate
19-hydroxy-17-(1h-indol-3-ylmethyl)-7,14,15-trimethyl-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-diene-2,5-dione
C29H34N2O4 (474.25184440000004)
(2s,3s,4r,5r)-2-{[(4s,6s,6ar,9s)-1-hydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalen-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate
(8r,9s,10s)-3,4,14,15,16-pentamethoxy-9,10-dimethyl-8-(2-methylpropoxy)tricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-5-ol
13-(acetyloxy)-4,8,8,11,15-pentamethyl-7,12-dioxo-3-oxatricyclo[11.3.0.0²,⁴]hexadec-10-en-16-yl 2-methylbut-2-enoate
(4r)-4-[(1r,3ar,4s,5ar,9as,11s,11ar)-4,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid
1-(acetyloxy)-5-methoxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-3-oxo-1h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl butanoate
3,5-dihydroxy-2-{[1-hydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalen-2-yl]oxy}oxan-4-yl acetate
methyl 4-methoxy-2-(methoxymethylidene)-3-methyl-6-(3-{2-[(2-methylbut-3-en-2-yl)oxy]propan-2-yl}-2,3-dihydro-1,4-benzodioxin-6-yl)hex-5-enoate
8-(acetyloxy)-10-[4-hydroxy-5-(2-methylprop-1-en-1-yl)-2-oxooxolan-3-ylidene]-3,7-dimethyldeca-2,6-dien-1-yl 2-methylbut-2-enoate
(3s)-5-{[(1s,2r,4as,8as)-2-hydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]methoxy}-3,7-dimethoxy-6-methyl-1-oxo-3h-2-benzofuran-4-carbaldehyde
(1r,5r,6as,7s,8s,9s,10as)-1-(acetyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-3-oxo-1h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl butanoate
(1s,3s,3ar,4s,5ar,9as,11ar)-3,4-dihydroxy-1-[(3s)-3-(hydroxymethyl)-5-oxooxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthrene-7,10-dione
4,5-dihydroxy-6-{[2-hydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalen-1-yl]oxy}oxan-3-yl acetate
4-(acetyloxy)-2,6,6,9-tetramethyl-5-[(2-methylbut-2-enoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undecan-3-yl 2-methylbut-2-enoate
4-hydroxy-4-{4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid
3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-2-[(3,4,5-trihydroxyoxan-2-yl)oxy]-5,6,6a,7,8,9-hexahydro-4h-phenalen-1-yl acetate
(3r)-5-{[(1s,2r,4as,8as)-2-hydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]methoxy}-3,7-dimethoxy-6-methyl-1-oxo-3h-2-benzofuran-4-carbaldehyde
4,7,11-trihydroxy-3a,6,6,9a,11a-pentamethyl-1-(2-methyl-5-oxooxolan-2-yl)-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-3,10-dione
(3r,4s,5s,6s)-6-{[(4s,6s,6ar,9s)-1-hydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalen-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate
(1r,2r,3s,4r,5s,7s,8s,9r)-4-(acetyloxy)-2,6,6,9-tetramethyl-5-{[(2z)-2-methylbut-2-enoyl]oxy}-11-oxotricyclo[5.4.0.0²,⁸]undecan-3-yl (2z)-2-methylbut-2-enoate
(3ar,6s,6ar,10s,15as)-1,6-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10-trimethyl-3h,3ah,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindole-12,15-dione
C29H34N2O4 (474.25184440000004)
(3s,3ar,6s,6ar,10s,15ar)-1,6-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10-trimethyl-3h,3ah,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindole-12,15-dione
C29H34N2O4 (474.25184440000004)
4-[3-(acetyloxy)-6-methylhepta-1,5-dien-2-yl]-1-methyl-3-[(2-methylbut-2-enoyl)oxy]-7-oxabicyclo[4.1.0]heptan-2-yl 2-methylbut-2-enoate
(4r)-4-[(1r,3ar,4s,5as,9as,11s,11ar)-4,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid
(4s)-4-[(1s,3ar,4s,5ar,9as,11ar)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxypentanoic acid
4-[7-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid
3a-(acetyloxy)-13-hydroxy-2,5,8,8-tetramethyl-12-methylidene-4,9-dioxo-1h,2h,3h,7h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl 2-methylbut-2-enoate
(1s,2s,3r,4s,6s)-4-[(3s)-3-(acetyloxy)-6-methylhepta-1,5-dien-2-yl]-1-methyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}-7-oxabicyclo[4.1.0]heptan-2-yl (2z)-2-methylbut-2-enoate
(4r)-4-[(1r,3ar,5ar,7s,9as,11s,11ar)-7,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid
(2s)-2-[(2s,3r)-2-[(1-hydroxyethylidene)amino]-n,3-dimethylpentanamido]-n-[(1z)-2-(1h-indol-3-yl)ethenyl]-3-phenylpropanimidic acid
C28H34N4O3 (474.26307740000004)
(2s)-2-[(2s)-2-[(1-hydroxyethylidene)amino]-n,4-dimethylpentanamido]-n-[(1z)-2-(1h-indol-3-yl)ethenyl]-3-phenylpropanimidic acid
C28H34N4O3 (474.26307740000004)
8-(acetyloxy)-5,6-dimethyl-5-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl 2-methylbut-2-enoate
4-{7,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid
(2r,3r,4s,5s)-2-{[(4s,6s,6ar,9s)-1-hydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalen-2-yl]oxy}-3,5-dihydroxyoxan-4-yl acetate
[(1r,3as,3bs,4s,7r,9as,9bs,10r,11ar)-4,7-bis(acetyloxy)-1-ethenyl-10-hydroxy-11a-methyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9a-yl]methyl acetate
(1s,7e,9s,12s,13s,14s)-14-(acetyloxy)-9-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-3,7,16-trien-12-yl 3-methylbutanoate
14-(acetyloxy)-9-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-3,7,16-trien-12-yl 3-methylbutanoate
(1s,7s,9e,11r,12s,14r,15s,16r,17s)-19-hydroxy-17-(1h-indol-3-ylmethyl)-7,14,15-trimethyl-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-diene-2,5-dione
C29H34N2O4 (474.25184440000004)
1,6-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10-trimethyl-3h,3ah,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindole-12,15-dione
C29H34N2O4 (474.25184440000004)
(1s,2r,4r,5s,9s,13r,17s,18s,20s)-9-formyl-5,9,13-trimethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate
4,5-dihydroxy-2-{[1-hydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalen-2-yl]oxy}oxan-3-yl acetate
(3s,3ar,6s,6ar,10s)-1,6-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10-trimethyl-3h,3ah,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindole-12,15-dione
C29H34N2O4 (474.25184440000004)
(1s,5s,7r,13r,14s,17s,19r)-10-hydroxy-5,7-dimethoxy-1,14,18,18-tetramethyl-2,6-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10-trien-17-yl acetate
methyl (2e,5e)-4-methoxy-2-(methoxymethylidene)-3-methyl-6-(3-{2-[(2-methylbut-3-en-2-yl)oxy]propan-2-yl}-2,3-dihydro-1,4-benzodioxin-6-yl)hex-5-enoate
(2r,3s,4r,5r)-2-{[(4s,6s,6ar,9s)-1-hydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalen-2-yl]oxy}-3,5-dihydroxyoxan-4-yl acetate
4-[(1r,3ar,4s,5ar,9as,11ar)-4,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid
(3s,4r,5r,6r)-6-{[(4s,6s,6ar,9s)-1-hydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalen-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate
(2s)-2-[(2s,3r)-2-[(1-hydroxyethylidene)amino]-n,3-dimethylpentanamido]-n-[(1e)-2-(1h-indol-3-yl)ethenyl]-3-phenylpropanimidic acid
C28H34N4O3 (474.26307740000004)
(1s,3ar,4s,5ar,7s,9as,11s,11ar)-4,7,11-trihydroxy-3a,6,6,9a,11a-pentamethyl-1-[(2s)-2-methyl-5-oxooxolan-2-yl]-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-3,10-dione
4,7,11-trihydroxy-3a,6,6,9a,11a-pentamethyl-1-(3-methyl-5-oxooxolan-3-yl)-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-3,10-dione
(4s)-4-[(1r,3ar,4s,5ar,9as,11s,11ar)-4,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid
(1r,2s,4s,10e,13r,15s,16s)-13-(acetyloxy)-4,8,8,11,15-pentamethyl-7,12-dioxo-3-oxatricyclo[11.3.0.0²,⁴]hexadec-10-en-16-yl (2e)-2-methylbut-2-enoate
methyl (2z,5e)-4-methoxy-2-(methoxymethylidene)-3-methyl-6-(3-{2-[(2-methylbut-3-en-2-yl)oxy]propan-2-yl}-2,3-dihydro-1,4-benzodioxin-6-yl)hex-5-enoate
(2z,6e,8s)-8-(acetyloxy)-10-[(3e,4s,5r)-4-hydroxy-5-(2-methylprop-1-en-1-yl)-2-oxooxolan-3-ylidene]-3,7-dimethyldeca-2,6-dien-1-yl (2z)-2-methylbut-2-enoate
[5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxo-4-(propanoyloxy)tetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-7-yl]methyl 2-methylpropanoate
(1r,7s,9e,11r,12s,14r,15s,16r,17s)-19-hydroxy-17-(1h-indol-3-ylmethyl)-7,14,15-trimethyl-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-diene-2,5-dione
C29H34N2O4 (474.25184440000004)